Biotechnology
RemeGen Celebrates World Intellectual Property Day 2023
YANTAI, China, April 26, 2023 /PRNewswire/ -- RemeGen Co., Ltd.
2023-04-26 10:00
2338
Call for submissions for the 6th edition of the SophI.A Summit, the annual event for academic and business research on artificial intelligence
* National and international researchers and R&D leaders are invited to submit their work for presentation as a conference, a poster or a demonstration. * The most promising communications will be awarded Special Prizes which include grants of several thousand euros. SOPHIA ANTIPOLIS, ...
2023-04-25 22:05
1806
Emmes Applauded by Frost & Sullivan for Streamlining Clinical Trials and for Its Competitive Strategies
Emmes collaborates with pharmaceutical companies as strategic partners, providing one-stop clinical trial services, reducing costs, and accelerating development. SAN ANTONIO, April 25, 2023 /PRNewswire/ -- Frost & Sullivan researched the contract research organizations industry and, based on its...
2023-04-25 20:30
1532
Wellcome Leap & Temasek Trust Launch US$60M Dynamic Resilience Programme to Extend Health Spans
* Average human life expectancy has doubled from 35 to 70 years over the past century[1], but health spans (number of years spent in good health) have not correspondingly improved[2] * Multimorbidity (multiple coexisting health conditions) poses an urgent challenge for global health service...
2023-04-25 20:03
1664
Biotech firm Gene Solutions: A promising picture for multi-cancer early detection in Southeast Asia
HO CHI MINH CITY, Vietnam, April 25, 2023 /PRNewswire/ -- In January 2023,
Vietnam's Medical Genetics Institute & Gene Solutions
2023-04-25 12:00
1863
BMC H-80 series: empowering breathing solutions for breathing and oxygen therapy
BEIJING, April 24, 2023 /PRNewswire/ -- Recently, the H-80 series Respiratory High-Flow Therapy Device has added more comprehensive monitoring indicators for even greater convenience and efficiency to help people in respiratory failure. April is a crucial month to prioritize the respiratory hea...
2023-04-24 20:00
1593
Belief BioMed Announces a Key Milestone of Dosing Completion for All Subjects in its Registrational Clinical Trial of BBM-H901
SHANGHAI, April 24, 2023 /PRNewswire/ -- Belief BioMed Group (BBM), an industry-leading biotech company focusing on innovative gene therapies, announced today the completion of patient dosing in its Phase III Registrational Clinical Trial (CTR20212816) of BBM-H901, a gene therapy for Hemophilia ...
2023-04-24 10:23
2049
SCG Cell Therapy to Present Late-Breaking Data at the International Society for Cell & Gene Therapy (ISCT) Highlighting Promising Antitumor and Antiviral Activities of SCG101 in Treating HBV-Related Hepatocellular Carcinoma
SINGAPORE, April 24, 2023 /PRNewswire/ -- Singapore based SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced that late-breaking data from the company's TCR-T therapy pipeline...
2023-04-24 10:00
2127
Earth Day: Angel Yeast Sets Out Green Manufacturing Roadmap, advancing sustainable development
SHANGHAI, April 22, 2023 /PRNewswire/ -- In honor of Earth Day, Angel Yeast (SH600298), the world's leading yeast manufacturer, is accentuating its expanded commitment to building a conservation-oriented, environmentally friendly enterprise and contributing to achieving the "Dual Carbon" goals t...
2023-04-22 20:00
7090
For Earth Day 2023, Tianlong Champions the Safeguarding of Food Safety with Its Biolum Portable ATP Hygiene Monitoring System
XI'AN, China, April 21, 2023 /PRNewswire/ -- Tianlong
2023-04-21 20:43
15487
Veeva Pulse Reveals Digital Content More Than Twice as Effective in Driving Promotional Response Globally
Significant opportunity for biopharmas as only 39% of HCP meetings across the
globe today present digital content
SINGAPORE, April 20, 2023 /PRNewswire/ -- Veeva Systems
2023-04-20 16:23
3189
BioMed Technology Funded by Alibaba Hong Kong Entrepreneurs Fund, Gobi and TIMC to Realise Precision and Personalised Gut Microbiome Management for Wellness
HONG KONG, April 20, 2023 /PRNewswire/ -- BioMed Technology Holdings Limited (BioMed),Hong Kong's leading microbiome startup, has raised USD 2 million in its latest oversubscribed seed round from Alibaba Hong Kong Entrepreneurs Fund (AEF), Gobi Partners GBA and The International Medical Co. Ltd. ...
2023-04-20 16:15
3547
Innovent Announces Overall Survival Results of Phase 2 Study of Pemazyre® (pemigatinib) in Chinese Patients with Advanced Cholangiocarcinoma Presented at AACR Annual Meeting 2023
ROCKVILLE, Md. and SUZHOU, China, April 20, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology a...
2023-04-20 08:00
3674
Ajinomoto Bio-Pharma Services Receives FDA Approval for High Potency Fill Line
SAN DIEGO, April 19, 2023 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that the United States Food and Drug Administration (FDA) has approved the company's high pot...
2023-04-19 20:05
1748
Biosyngen announces FDA IND approval of its second product for EBV-positive lymphoma
GUANGZHOU, China, April 18, 2023 /PRNewswire/ -- April 15, 2023, Biosyngen Pte Ltd (hereinafter as "Biosyngen") announced that the Company received IND approval for its second product in the pipeline, a T-cell redirection therapy for the treatment of EBV-positive lymphoma. A week prior to this, t...
2023-04-18 19:03
3110
YS Biopharma Announces Record Vaccine Revenues and Preliminary Financial Results for FY2023 Ended March 31, 2023
FY2023 Revenues Increased by Approximately 30% Year Over Year GAITHERSBURG, Md., April 18, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and commercializing new ...
2023-04-18 19:00
2237
Daewoong Pharmaceutical and Sygnature Discovery announce drug discovery research collaboration
- 'Daewoong Pharmaceutical enters research collaboration to discover a novel small molecule to target autoimmune diseases using fragment-based drug discovery and virtual high throughput screening SEOUL, South Korea and NOTTINGHAM, England, April 18, 2023 /PRNewswire/ -- Daewoong Pharmaceuti...
2023-04-18 17:16
2268
Innovent Releases Final Analysis Results of ORIENT-16: the Phase 3 Study of Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric Cancer at the AACR Annual Meeting 2023
ROCKVILLE, Md. and SUZHOU, China, April 18, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology a...
2023-04-18 08:00
2372
Ocedurenone: A Novel Therapy for Uncontrolled Hypertension in Advanced Chronic Kidney Disease
PRINCETON, N.J., April 18, 2023 /PRNewswire/ -- EMJ Nephrology interviewed two World-renowned experts in nephrology and cardiology,George Bakris and Faiez Zannad, regarding the challenges of treating uncontrolled hypertension (uHTN) in patients with advanced chronic kidney disease (CKD), a large ...
2023-04-18 08:00
1879
Innovent Announces Updated Data of Phase 1 Clinical Trial for IBI351 (KRAS[G12C] Inhibitor) as Monotherapy for Solid Tumors at the AACR Annual Meeting 2023
ROCKVILLE, Md. and SUZHOU, China, April 18, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmolog...
2023-04-18 08:00
2483
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 291 media titles]
2024-04-30 10:11
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 249 media titles]
2024-04-30 15:13New International Land-Sea Trade Corridor achieves rapid development
[Picked up by 246 media titles]
2024-04-28 10:24Most Read
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2931
